全文获取类型
收费全文 | 374103篇 |
免费 | 45127篇 |
国内免费 | 3210篇 |
专业分类
耳鼻咽喉 | 7242篇 |
儿科学 | 11064篇 |
妇产科学 | 6658篇 |
基础医学 | 32045篇 |
口腔科学 | 5710篇 |
临床医学 | 49036篇 |
内科学 | 93378篇 |
皮肤病学 | 10427篇 |
神经病学 | 37316篇 |
特种医学 | 15938篇 |
外国民族医学 | 13篇 |
外科学 | 75349篇 |
综合类 | 2753篇 |
现状与发展 | 73篇 |
一般理论 | 177篇 |
预防医学 | 23108篇 |
眼科学 | 8651篇 |
药学 | 16271篇 |
1篇 | |
中国医学 | 325篇 |
肿瘤学 | 26905篇 |
出版年
2024年 | 785篇 |
2023年 | 5806篇 |
2022年 | 3272篇 |
2021年 | 8134篇 |
2020年 | 8642篇 |
2019年 | 7000篇 |
2018年 | 12927篇 |
2017年 | 11269篇 |
2016年 | 12655篇 |
2015年 | 13521篇 |
2014年 | 22833篇 |
2013年 | 25813篇 |
2012年 | 22236篇 |
2011年 | 23010篇 |
2010年 | 19710篇 |
2009年 | 22584篇 |
2008年 | 21194篇 |
2007年 | 20299篇 |
2006年 | 22184篇 |
2005年 | 19472篇 |
2004年 | 17789篇 |
2003年 | 15559篇 |
2002年 | 15063篇 |
2001年 | 5495篇 |
2000年 | 4245篇 |
1999年 | 5029篇 |
1998年 | 6202篇 |
1997年 | 5484篇 |
1996年 | 5079篇 |
1995年 | 4789篇 |
1994年 | 3348篇 |
1993年 | 2963篇 |
1992年 | 2275篇 |
1991年 | 2252篇 |
1990年 | 1792篇 |
1989年 | 1861篇 |
1988年 | 1641篇 |
1987年 | 1421篇 |
1986年 | 1479篇 |
1985年 | 1353篇 |
1984年 | 1421篇 |
1983年 | 1277篇 |
1982年 | 1521篇 |
1981年 | 1347篇 |
1980年 | 1178篇 |
1979年 | 752篇 |
1978年 | 832篇 |
1977年 | 825篇 |
1976年 | 638篇 |
1975年 | 583篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
993.
Prospective, Double-Blind, Randomized, Parallel-Group, Dose-Ranging Study of Botulinum Toxin Type A in Men with Glabellar Rhytids 总被引:3,自引:0,他引:3
BACKGROUND: The effective dose for treating glabellar lines with botulinum toxin type A in men has not been studied adequately. OBJECTIVE: To compare the safety, efficacy, and duration of response of four doses of botulinum toxin type A on glabellar rhytids in men. METHODS: Eighty men were randomized to receive a total dose of either 20, 40, 60, or 80 U of botulinum toxin type A (BOTOX, BOTOX Cosmetic, or Vistabel, Allergan, Inc., Irvine, CA, USA) in the glabellar area. Glabellar lines were assessed at rest and maximum frown by a trained observer at baseline, 2 and 4 weeks, and monthly thereafter. Patients provided self-evaluations at the same visits. Adverse events were monitored throughout. RESULTS: The 40, 60, and 80 U doses of botulinum toxin type A were consistently more effective in reducing glabellar lines than the 20 U dose (duration, peak response rate, improvement from baseline). There was a dose-dependent increase in both the response rate at maximum frown and the duration of effect assessed by the trained observer. In addition, the participants reported a dose-dependent reduction in the ability to frown, improvement in their global assessment, and increased feelings of attractiveness, self-confidence, and satisfaction. The incidence of adverse events was not increased with higher doses. CONCLUSION: Male participants with glabellar rhytids benefit from starting doses of at least 40 U of botulinum toxin type A. 相似文献
994.
995.
996.
997.
Legionnaire's disease was first identified and described in January 1977. Even today, it is often regarded as an unusual or exotic disease, when in fact it is a very common form of community and nosocomial acquired pneumonia. The major roles of the acute care nurse, including patient health education; psychosocial needs of the patient; and strategies for disease prevention and control, are discussed. 相似文献
998.
999.
1000.